As shown in Figure 2B, MTL levels in the FC group were nearly twice those in the CON group, with a substantial increase in the BDF-H group, doubling MTL levels compared to the FC group
In addition, a 2024 study found that people taking another GLP-1 drug, liraglutide, had a 179% higher risk of developing NAION
Analysis of CE molecular species was performed as previously described 59
Regarding fibrosis, while direct anti-fibrotic mechanisms are less established, preclinical studies indicate that GLP-1 RAs could suppress fibrogenic cell activation and reduce expression of pro-fibrotic genes encoding extracellular matrix proteins, potentially facilitating fibrosis regression in conjunction with improvements in steatosis and inflammation [29-32]
4, 2015, pp
People on GLP-1 drugs stop wanting filling foods first, so protein crashes harder than carbs or fat in the average patients intake log